MTIX Micro Therapeutics (MM)

ev3 International Files Lawsuit Against Distributors in Hong Kong and Phoenix PLYMOUTH, Minn., Nov. 10 /PRNewswire/ -- On October 29, 2004, ev3 International, Inc. commenced a lawsuit against Advanced Medical China Hong Kong Ltd. and Kevin James MacDonald in United States District Court for the District of Minnesota. The lawsuit alleges that Advanced Medical China Hong Kong Ltd. and Kevin MacDonald have breached the distribution agreements they entered into with ev3 International, Inc., by failing to pay more than $750,000 for medical device products sold to Advanced Medical China Hong Kong Ltd. Kevin MacDonald is also a Director of Arizona Heart Institute (AHI), HKG Limited, RCF Company Limited and RCFM Company Limited. In addition, he is Legal Representative and Chairman of the Board of Directors of Beijing International Heart Hospital. About ev3 ev3 International, Inc,, is a wholly owned subsidiary, of ev3 Inc., a privately held company based in Plymouth, Minnesota, and founded in 2001. ev3 Inc. is a global medical device company that is focused on innovative endovascular technologies for the minimally invasive treatment of coronary, neurovascular, and peripheral vascular diseases and disorders. In 2001, ev3 established a strategic relationship with Micro Therapeutics, Inc. (NASDAQ:MTIX), a leader in the market for catheter-based neurovascular devices. ev3 Inc. and Micro Therapeutics, Inc., are majority owned by ev3 LLC, a private equity partnership organized by Warburg Pincus and the Vertical Group, two of the most successful institutional investors in the medical device industry. More information about ev3 and its products can be found at http://www.ev3.net/ . DATASOURCE: ev3 International, Inc. CONTACT: Cheryl Newell, CFO of ev3 International, Inc., +1-763-398-7000, ; Nancy A. Johnson, +1-612-455-1745, , or Marian Briggs, +1-612-455-1742, , both of Padilla Speer Beardsley Web Site: http://www.ev3.net/

Copyright